Skip to main content

Table 4 Patterns of nodal recurrence

From: Whether individualized dose escalation should be recommended for lymph nodes with different sizes in the definitive radiotherapy of cervical cancer?

Patients

n (%)

All patients

1310

Patients with nodal recurrence

90 (9.0%)

 Pelvic

22 (24.4%)

 Para-aortic

42 (46.6%)

 Supraclavicular

27 (30%)

 Inguinal

5 (5.6%)

 Mediastinal

4 (4.4%)

 Axillary

2 (2.2%)

Patients with nodal recurrence

90

 Single region

76 (84.4%)

  Pelvic

19 (21.1%)

  Para-aortic

33 (36.7%)

  Supraclavicular

19 (21.1%)

  Inguinal

4 (4.4%)

  Axillary

1 (1.1%)

 Multiple regions

24 (26.7%)

Patients with nodal recurrence

90

 Inside the target

25 (27.8%)

 Outside the target

62 (68.9%)

 Inside and outside target

3 (3.3%)